Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 0
  • Market Cap: £5.37m
  • Beta: 0.00

Regulatory News

Holding(s) in Company 08-Sep-2025 11:38 RNS
Ox-1 Patent Grant & Development Programme Update 04-Sep-2025 07:00 RNS
Holding(s) in Company 04-Aug-2025 15:27 RNS
Manufacturing Scale Up of Lead Ox-1 Programme 17-Jul-2025 07:00 RNS
Result of AGM 09-Jul-2025 15:07 RNS
AGM Statement 09-Jul-2025 07:00 RNS
Notice of AGM 16-Jun-2025 16:10 RNS
Change of Adviser 13-Jun-2025 07:00 RNS
Final results for year to 31 March 2025 03-Jun-2025 07:00 RNS
Notice of Results and Ox-1 presentation 23-May-2025 07:14 RNS
Holding(s) in Company 22-May-2025 12:43 RNS
Director/PDMR Shareholding 22-May-2025 12:22 RNS
Holding(s) in Company 16-May-2025 13:00 RNS
Master Service Agreement signed for Ox-1 programme 12-May-2025 07:00 RNS
Board Appointment, Grant of Options, PDMR Dealing 01-May-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.22
52 Week Low 0.20
Volume 0
Shares Issued 2,148.96m
Market Cap £5.37m
Beta 0.00

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average
90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average
Price Trend
86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average
72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page